Climb Bio (CLYM)
NASDAQ:CLYM
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -97.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -67.88M | $ -82.02M | $ -40.27M | $ -45.13M | $ -35.67M |
| EBITDA | $ -67.79M | $ -30.36M | $ -40.27M | $ -45.13M | $ -35.67M |
| Net Income | $ -59.85M | $ -73.90M | $ -35.12M | $ -45.24M | $ -47.48M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 101.08M | $ 150.92M | $ 106.80M | $ 123.57M | $ 136.48M |
| Total Assets | $ 167.74M | $ 217.19M | $ 110.47M | $ 134.99M | $ 173.24M |
| Total Debt | $ 541.00K | $ 532.00K | $ 349.00K | $ 480.00K | $ 0.00 |
| Net Debt | $ -35.14M | $ -86.70M | $ -92.76M | $ -43.10M | $ -46.92M |
| Total Liabilities | $ 7.27M | $ 5.31M | $ 2.87M | $ 6.28M | $ 6.04M |
| Stockholders' Equity | $ 160.47M | $ 211.88M | $ 107.60M | $ 128.72M | $ 167.20M |
| Cash Flow | |||||
| Free Cash Flow | $ -54.54M | $ -15.56M | $ -20.60M | $ -37.37M | $ -36.07M |
| Operating Cash Flow | $ -54.36M | $ -15.56M | $ -20.60M | $ -37.37M | $ -36.07M |
| Investing Cash Flow | $ 2.83M | $ -121.09M | $ 68.98M | $ 34.44M | $ -114.97M |
| Financing Cash Flow | $ -21.00K | $ 130.73M | $ 841.00K | $ 0.00 | $ 177.23M |